Ironwood Pharmaceuticals

IRWD · NASDAQ

$3.63+$0.07 (+1.97%)TodayMarket closed · Oct 20, 7:45 PM ET

Prev close $3.56

IRWD analyst rating

BuyConsensus of 3 analysts over the last 12 months. 67% rate it a buy.

Strong buy0
Buy2
Hold1
Underperform0
Sell0

12-month price target · 6 analysts

Average $6.22 (+71.4% upside)

Low: $3.74
Now: $3.63
High: $10.50

Upgrades and downgrades

The latest rating actions, newest first

IRWD analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Citizens	Feb 26, 2026	Maintains	Market Outperform	$8.00 → $10.00	41%
Wells Fargo	Jan 5, 2026	Maintains	Equal-Weight	$3.00 → $5.00	68%
Citizens	Jan 5, 2026	Upgrade	Market Perform → Market Outperform	$8.00	52%
Wells Fargo	Nov 11, 2025	Maintains	Equal-Weight	$1.00 → $3.00	68%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.